Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine

Barak Mizrahi, Roni Lotan (), Nir Kalkstein, Asaf Peretz, Galit Perez, Amir Ben-Tov, Gabriel Chodick, Sivan Gazit and Tal Patalon
Additional contact information
Barak Mizrahi: KI Research Institute
Roni Lotan: Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services
Nir Kalkstein: KI Research Institute
Asaf Peretz: Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services
Galit Perez: Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services
Amir Ben-Tov: Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services
Gabriel Chodick: Sackler Faculty of Medicine, Tel Aviv University
Sivan Gazit: Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services
Tal Patalon: Kahn Sagol Maccabi (KSM) Research & Innovation Center, Maccabi Healthcare Services

Nature Communications, 2021, vol. 12, issue 1, 1-5

Abstract: Abstract The short-term effectiveness of a two-dose regimen of the BioNTech/Pfizer mRNA BNT162b2 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine was widely demonstrated. However, long term effectiveness is still unknown. Leveraging the centralized computerized database of Maccabi Healthcare Services (MHS), we assessed the correlation between time-from-vaccine and incidence of breakthrough infection between June 1 and July 27, the date of analysis. After controlling for potential confounders as age and comorbidities, we found a significant 1.51 fold (95% CI, 1.38–1.66) increased risk for infection for early vaccinees compared to those vaccinated later that was similar across all ages groups. The increased risk reached 2.26- fold (95% CI, 1.80–3.01) when comparing those who were vaccinated in January to those vaccinated in April. This preliminary finding of vaccine waning as a factor of time from vaccince should prompt further investigations into long-term protection against different strains.

Date: 2021
References: View complete reference list from CitEc
Citations: View citations in EconPapers (6)

Downloads: (external link)
https://www.nature.com/articles/s41467-021-26672-3 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-26672-3

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-021-26672-3

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().